KETAMINE HYDROCHLORIDE injection, solution, concentrate

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

即購入

ダウンロード 製品の特徴 (SPC)
24-04-2023

有効成分:

KETAMINE HYDROCHLORIDE (UNII: O18YUO0I83) (KETAMINE - UNII:690G0D6V8H)

から入手可能:

Medical Purchasing Solutions, LLC

投与経路:

INTRAMUSCULAR

処方タイプ:

PRESCRIPTION DRUG

適応症:

Ketamine Hydrochloride Injection is indicated: - as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. - for the induction of anesthesia prior to the administration of other general anesthetic agents. - as a supplement to other anesthetic agents. - Ketamine Hydrochloride Injection is contraindicated in patients for whom a significant elevation of blood pressure would constitute a serious hazard [see Warnings and Precautions (5.1)] . - Ketamine Hydrochloride Injection is contraindicated in patients with known hypersensitivity to ketamine or to any excipient [see Adverse Reactions (6)] . Risk Summary There are no adequate and well-controlled studies of Ketamine Hydrochloride Injection in pregnant women. In animal reproduction studies in rats developmental delays (hypoplasia of skeletal tissues) were noted at 0.3 times the human intramuscular dose of

製品概要:

How Supplied Ketamine Hydrochloride Injection, USP is a clear colorless solution supplied as the hydrochloride in concentrations equivalent to ketamine base. NDC 0409-2051-05 Box of 10 5 mL Multiple-dose Fliptop Vial 500 mg/5 mL (100 mg/mL) NDC 0409-2053-10 Box of 10 10 mL Multiple-dose Fliptop Vial 500 mg/10 mL (50 mg/mL) Storage and Handling Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature]. Protect from light.

認証ステータス:

Abbreviated New Drug Application

製品の特徴

                                KETAMINE HYDROCHLORIDE- KETAMINE HYDROCHLORIDE INJECTION, SOLUTION,
CONCENTRATE
MEDICAL PURCHASING SOLUTIONS, LLC
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
KETAMINE
HYDROCHLORIDE INJECTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING
INFORMATION FOR
KETAMINE HYDROCHLORIDE INJECTION.
KETAMINE HYDROCHLORIDE INJECTION, FOR INTRAVENOUS OR INTRAMUSCULAR
USE, CIII
INITIAL U.S. APPROVAL: 1970
RECENT MAJOR CHANGES
Warnings and Precautions, Drug Induced Liver Injury ( 5.6)
7/2022
INDICATIONS AND USAGE
Ketamine Hydrochloride Injection is a general anesthetic indicated:
as the sole anesthetic agent for diagnostic and surgical procedures
that do not require skeletal muscle
relaxation ( 1)
for the induction of anesthesia prior to the administration of other
general anesthetic agents ( 1)
as a supplement to other anesthetic agents. ( 1)
DOSAGE AND ADMINISTRATION
See Full Prescribing Information for important dosage and
administration instructions. ( 2)
Induction of Anesthesia:
-- _Intravenous Route_: Initially, 1 to 4.5 mg/kg administered slowly
(over a period of 60 seconds).
Alternatively, administer a dose of 1 to 2 mg/kg at a rate of 0.5
mg/kg/min. ( 2.2)
-- _Intramuscular Route_: Initially, 6.5 to 13 mg/kg. ( 2.2)
Maintenance of Anesthesia: Increments of one-half to the full
induction dose may be repeated as
needed ( 2.2). Adjust the dose according to the patient's anesthetic
needs and whether an additional
anesthetic agent is employed. ( 2.2)
Supplement to Other Anesthetic Agents: The regimen of a reduced dose
of Ketamine Hydrochloride
Injection supplemented with diazepam can be used to produce balanced
anesthesia by combination
with other agents. ( 2.2)
DOSAGE FORMS AND STRENGTHS
Injection: 500 mg/10 mL (50 mg/mL) and 500 mg/5 mL (100 mg/mL)
multiple-dose vials. ( 3)
CONTRAINDICATIONS
In patients for whom a significant elevation of blood pressure would
be a serious hazard. ( 4)
Known hypersensitivity to ketamine or to any excipient. ( 4)
WARNINGS AN
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索